Engle James R 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Dec 2, 2010
Insider Transaction Report
Form 4
Engle James R
Sr. VP, Information Technology
Transactions
- Exercise/Conversion
Options (right to buy)
2010-12-01$1.39/sh−27,408$38,097→ 28,464 totalExercise: $1.39From: 2006-04-01Exp: 2015-11-10→ Common Stock (27,408 underlying) - Exercise/Conversion
Common Stock
2010-12-01$1.39/sh+27,408$38,097→ 30,039 total - Sale
Common Stock
2010-12-01$21.50/sh−27,408$589,272→ 2,631 total
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2010.
- [F2]The number of shares reported includes restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F3]The option is fully vested and immediately exercisable.